Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin. - Wikidata - wikimedia - TriplyDB

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

http://www.wikidata.org/entity/Q46615053

about

The function of SARI in modulating epithelial-mesenchymal transition and lung adenocarcinoma metastasis Role of DAB2IP in modulating epithelial-to-mesenchymal transition and prostate cancer metastasis.Role of hepatitis B surface antigen in the development of hepatocellular carcinoma: regulation of lymphoid enhancer-binding factor 1 The Ras-ERK and PI3K-mTOR pathways: cross-talk and compensation FGF19 as a postprandial, insulin-independent activator of hepatic protein and glycogen synthesis Knockin of mutant PIK3CA activates multiple oncogenic pathways Mammary tumorigenesis and metastasis caused by overexpression of insulin receptor substrate 1 (IRS-1) or IRS-2 Rewired ERK-JNK signaling pathways in melanoma Role of Sex Hormones in the Development and Progression of Hepatitis B Virus-Associated Hepatocellular Carcinoma Molecular mechanism of hepatitis B virus-induced hepatocarcinogenesis GSK-3 as potential target for therapeutic intervention in cancer Potential mechanisms of hepatitis B virus induced liver injury Signaling cross-talk in the resistance to HER family receptor targeted therapy Analysis of the role of Igf2 in adrenal tumour development in transgenic mouse models Histone methylation modifiers in cellular signaling pathways Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma Overexpression of insulin receptor substrate-1 and hepatitis Bx genes causes premalignant alterations in the liver Myricetin induces apoptosis by inhibiting P21 activated kinase 1 (PAK1) signaling cascade in hepatocellular carcinoma Andrographolide induces Nrf2 and heme oxygenase 1 in astrocytes by activating p38 MAPK and ERK Cellular and molecular mechanisms underlying alcohol-induced aggressiveness of breast cancer Thr 163 phosphorylation causes Mcl-1 stabilization when degradation is independent of the adjacent GSK3-targeted phosphodegron, promoting drug resistance in cancer GSK-3: Functional Insights from Cell Biology and Animal Models.Bone morphogenetic protein 2 induces pulmonary angiogenesis via Wnt-beta-catenin and Wnt-RhoA-Rac1 pathways.Stabilization of mismatch repair gene PMS2 by glycogen synthase kinase 3beta is implicated in the treatment of cervical carcinoma Brain-derived neurotrophic factor prevents phencyclidine-induced apoptosis in developing brain by parallel activation of both the ERK and PI-3K/Akt pathways.Activation of mitochondrial ERK protects cancer cells from death through inhibition of the permeability transition Selective inhibition of prostaglandin E2 receptors EP2 and EP4 induces apoptosis of human endometriotic cells through suppression of ERK1/2, AKT, NFkappaB, and beta-catenin pathways and activation of intrinsic apoptotic mechanisms.Molecular mechanisms of gender disparity in hepatitis B virus-associated hepatocellular carcinoma Phospholipase Cδ1 suppresses cell migration and invasion of breast cancer cells by modulating KIF3A-mediated ERK1/2/β- catenin/MMP7 signalling.A Hyper-Crosslinked Carbohydrate Polymer Scaffold Facilitates Lineage Commitment and Maintains a Reserve Pool of Proliferating Cardiovascular Progenitors.Virus associated malignancies: the role of viral hepatitis in hepatocellular carcinoma.CD133+ liver cancer stem cells from methionine adenosyl transferase 1A-deficient mice demonstrate resistance to transforming growth factor (TGF)-beta-induced apoptosis Molecular Signals Elicited by GPCR Agonists in Hypertension, Cardiovascular Remodeling: Are MMPs and ADAMs Elusive Therapeutic Targets?Identification of MAP kinase pathways as therapeutic targets in gallbladder carcinoma using targeted parallel sequencing.Inhibition of ERK1/2 Restores GSK3β Activity and Protein Synthesis Levels in a Model of Tuberous Sclerosis.Regorafenib inhibits colorectal tumor growth through PUMA-mediated apoptosis.Molecular Pathogenesis of Hepatitis-B-virus-associated Hepatocellular Carcinoma.Thyroid states regulate subcellular glucose phosphorylation activity in male mice.Genome-wide perturbations by miRNAs map onto functional cellular pathways, identifying regulators of chromatin modifiers Fibulin-3 suppresses Wnt/β-catenin signaling and lung cancer invasion.

P2860

Q21134555-A07C329D-4E51-47DC-BC30-7DE7FE6D9283 Q24295609-89EAAC7A-5810-40D2-9256-4483DA5BB06E Q24320028-CC9F62FD-A92A-42A8-BB89-4D391DF7A736 Q24616946-83462EAA-5C24-48D1-8894-578559AAFB68 Q24617480-DAF2C1FF-69DD-432E-9B99-ACE67A9BC2FE Q24657412-E904C096-948B-44D6-B10A-D428F80DB7F7 Q24672372-77C5AA01-662D-4E4F-A915-8C3059EEFC87 Q24683737-81FEF57B-057A-4FBA-800D-59BDA7FAECD1 Q26778413-62D869C9-174C-46FF-A88D-CDAAE20CE986 Q26823512-D2ABD81D-69AB-4325-AB75-8F474FA7669B Q27013811-C2CCCAF3-AC58-4296-AC3C-2172E88A3603 Q27014079-5DC9B5B1-8DD9-46AB-B9B5-B7C7BE5ED4BF Q27027778-E60DBCD7-C4D9-469A-B706-28BF62F90E17 Q27321080-B81C39D4-8F65-48B8-92D4-3BDCC63CC700 Q28082123-E38C5377-CF82-4183-A118-BAB846F3A69A Q28084948-0C00EC51-79F4-4F47-A84A-32B70DB82548 Q28246572-8B6BFCF5-5C35-4F83-AA8F-EFB88EC7FF77 Q28263921-9ED84989-44A8-4FED-BEC6-7FE769B6BA03 Q28389948-B4AC9204-8BE6-4001-BFD0-A2A5C132853F Q28397579-E68B0C72-3DD0-4D75-BAA3-4DB19A8215C8 Q28484291-FC84555D-4D0C-4EBF-A7A4-F3D38493766D Q30472813-C6218CFC-511B-48F2-953A-06D1FB6B0381 Q30485381-01786599-FEA9-47C8-8D0C-937B770E1D1D Q33533641-F414281A-CF6F-4B07-9B22-AF817832A0C0 Q33618318-BE79733D-54D7-4FB9-97D7-1DEDFCDB71DC Q33640002-EBDE08DF-8BE6-4311-BB38-21D87A35D7CF Q33642212-60A709A7-C9A2-4807-B9FB-1C385DE6B9CB Q33661172-60A1FCE3-4484-4C57-AF3D-58495646A491 Q33710002-BF4E01F8-724C-4D2C-9FC4-00AFCFB6A5B4 Q33719810-C3FBC8CC-58F1-411E-8553-1998612E2BCA Q33723810-F166DF67-1E1B-4DA5-90F9-707908FAC53F Q33786347-5C18138E-1B0D-4601-A9DC-AA7EE6F4FE53 Q33807091-FF428E1A-9FB3-4948-9CD2-D2AD17838C76 Q33829484-F1D1D388-CA26-4DD4-8C6D-F493703FCE74 Q33829976-D3639A97-756F-4476-B1A5-128096E6F324 Q33838524-330983C5-A44E-478F-9CB2-5C35557133AB Q33855801-1143617A-B46E-4782-AED8-D196F0EBCDD5 Q33904219-60DFE60E-D742-4C0F-9683-353D97EAB9E5 Q33917664-FDA69637-28D1-4D86-A9A2-B7C36BE6656F Q34009946-B8B428AC-8E71-4E3F-AAC2-8DD580837006

P2860

Erk associates with and primes GSK-3beta for its inactivation resulting in upregulation of beta-catenin.

http://www.wikidata.org/entity/Q46615053

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Erk associates with and primes ...... upregulation of beta-catenin.

@en

Erk associates with and primes ...... upregulation of beta-catenin.

@nl

type

label

Erk associates with and primes ...... upregulation of beta-catenin.

@en

Erk associates with and primes ...... upregulation of beta-catenin.

@nl

prefLabel

Erk associates with and primes ...... upregulation of beta-catenin.

@en

Erk associates with and primes ...... upregulation of beta-catenin.

@nl

P1433

Q46615053-016695CF-60CF-4C12-BBD5-4CFE20EDEAA2

P1476

Q46615053-9750A4D4-0FF0-48DA-B4FD-4DD5105EB001

P2093

Q46615053-151DD969-CD24-4DC4-A4A2-988AE48C934A

Q46615053-1EBBAEF3-5A19-4A2E-A4F3-08957D4638C5

Q46615053-21FD9E3C-DEDA-45D9-8ACC-8F4F16A110F4

Q46615053-26A2F77F-3A49-433F-947C-F6B9212206E6

Q46615053-33876460-EB71-4A75-BB0F-6AD231BD016E

Q46615053-4A6BE617-39F4-463C-BE45-48F8ED8449F1

Q46615053-53FD72C9-0527-4CFF-94BC-0B363DE1FEB1

Q46615053-5A01BF33-69E3-4170-9830-0FE82E0A7B53

Q46615053-8D5CDAB0-E78C-4A9B-A2C3-8B4FBF1142F5

Q46615053-8F2424A8-1AD9-4A00-A4CA-8C49E1C0F892

P304

Q46615053-E6CEA908-3D2D-4583-B856-D2F33961CD5C

P31

Q46615053-DA8996E1-49E9-458E-9D69-560FDCD6A722

P356

Q46615053-4AFC3E5C-F60F-4336-A5BB-ACA3520C8D2D

P433

Q46615053-D18C0639-DFB1-4846-9ABD-6DB353DE19AE

P478

Q46615053-B423EB9B-1D90-4D29-9A7A-3CF05696EFC4

P50

Q46615053-D147721C-1B02-46EB-959B-5E4CB77A2F68

P577

Q46615053-ED4E08BF-FD7F-4092-BBCF-451CD8120E2F

P5875

Q46615053-8633ADF9-F8D1-4033-9246-4E46AA6C1887

P698

Q46615053-18F5C544-64A6-4058-AE1D-DF131839C81C

P356

J.MOLCEL.2005.06.009

P1433

P1476

Erk associates with and primes ...... n upregulation of beta-catenin

@en

P2093

Chang-Hai Tsai

http://www.w3.org/2001/XMLSchema#string

Chien-Chen Lai

http://www.w3.org/2001/XMLSchema#string

Fuu-Jen Tsai

http://www.w3.org/2001/XMLSchema#string

Geoffrey Bartholomeusz

http://www.w3.org/2001/XMLSchema#string

Jaw-Ching Liu

http://www.w3.org/2001/XMLSchema#string

Jer-Yen Yang

http://www.w3.org/2001/XMLSchema#string

Jiahong Xia

http://www.w3.org/2001/XMLSchema#string

Jun Qin

http://www.w3.org/2001/XMLSchema#string

Mien-Chie Hung

http://www.w3.org/2001/XMLSchema#string

Qingqing Ding

http://www.w3.org/2001/XMLSchema#string

P304

159-170

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1016/J.MOLCEL.2005.06.009

http://www.w3.org/2001/XMLSchema#string

P433

2

http://www.w3.org/2001/XMLSchema#string

P478

19

http://www.w3.org/2001/XMLSchema#string

P50

P577

2005-07-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7705103

http://www.w3.org/2001/XMLSchema#string

P698

16039586

http://www.w3.org/2001/XMLSchema#string